Tectonic Therapeutic Inc. Ordinary Shares TECX 深 滬
已收盤 07-18 16:00:00 美东时间
21.91
-1.370
-5.88%
華盛通- 最 高23.775
- 今 開23.46
- 成交量 8.89万股
- 最 低 21.85
- 昨 收 23.28
- 總市值 4.09亿
- 52周最高 61.07
- 市盈率 靜 --
- 換手率 0.48%
- 52周最低 13.70
- 委 比 94.05%
- 總股本 1867.25万
- 歷史最高 644.40
- 量 比 0.32
- 振 幅 8.27%
- 歷史最低 6.72
- 每 手 1
- 風險率 11.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tectonic Therapeutic joins Russell 3000 index
Tectonic Therapeutic (NASDAQ:TECX) has been added to the broad-market Russell 3000 Index as part of the 2025 Russell US Indexes annual reconstitution. The addition is effective after the open of US eq...
06-30 21:21
Tectonic Therapeutic Joins Russell 3000® Index
Tectonic Therapeutic, Inc. has been added to the Russell 3000® Index following the 2025 Russell US Indexes annual reconstitution. The change will take effect after the US equity market open on June 30, 2025. The Russell 3000 Index includes the 3,000 largest US stocks by market capitalization and encompasses both the Russell 1000 and Russell 2000 indexes. Tectonic, a clinical-stage biotech company focused on developing therapeutic proteins and ant...
06-30 12:00
美股大行评级 | GitLab遭多家大行下调目标价！Stifel首予优步"买入"评级，目标价110美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139839943846023169.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Loop Capital：维持Dave & Buster's Enter(PLAY)"买入"评级，目标价从35美元升至46美元</p> <p>• Stifel：维持嘉年华(CCL)"买入"评级，目标价从31美元升至
06-12 09:46
Raymond James Reinstates Outperform on Tectonic Therapeutic, Announces $76 Price Target
Raymond James analyst Michael Freeman reinstates Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and announces $76 price target.
06-12 00:32
Tectonic Therapeutics shares are trading higher after the company announced it presented full Phase 1b results for TX45.
Tectonic Therapeutics shares are trading higher after the company announced it ...
05-20 00:16
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
Mizuho Maintains Outperform on Tectonic Therapeutic, Raises Price Target to $85
Mizuho analyst Uy Ear maintains Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and raises the price target from $51 to $85.
05-15 22:59
Tectonic Therapeutic Q1 EPS $(0.93) Beats $(1.22) Estimate
Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of $(1.22) by 23.77 percent. This is a 91.52 percent increase over losses of $(10.97) per share
05-09 04:14
美股大行评级 | 潜在涨幅3020.12%！Ascendiant Capital上调Plus Therapeutics目标价至20美元，维持"买入"评级
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
04-22 08:41
